INPLASY202060076

Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies A Systematic Review and Meta-analysis of Randomized Controlled Trials

Keywords: ibrutinib; B-cell malignancies; overall bleeding; major bleeding; risk

Download PDF - 202060076